The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Snehjeev Ventures Pvt Ltd & PACs
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Snehjeev Ventures Pvt Ltd along with persons acting in concert (Rushank S Lunkad, Sneha Lunkad, and Riddhi Lunkad) disclosed an open market acquisition of 32,000 equity shares (0.05%) of Amerise Biosciences Ltd on June 4, 2026. This pushed their combined holding from 46,18,896 shares (6.99%) to 46,50,896 shares (7.04%), crossing the 7% mark and triggering the Reg 29(2) disclosure requirement. The acquirer has clarified that they do not belong to the promoter or promoter group of the company. The company's total equity share capital stands at 66,06,900 shares of Rs. 10 each (Rs. 6.60 crore).
A non-promoter entity is gradually building a stake in Amerise Biosciences through open market purchases. While the incremental buy is small (0.05%), crossing the 7% threshold signals a creeping acquisition approach that shareholders should monitor, especially as the next major SAST trigger lies at the 10% mark.